Overview

Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
0
Participant gender:
All
Summary
Few randomized studies have focused on the optimal management of non-ICU patients with type 2 diabetes in Latin America. Objective: Compare safety and efficacy of a basal bolus regimen with analogs and human insulins in general medicine patients admitted to a University Hospital in Asuncion, Paraguay.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Universidad Nacional de Asunción
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc
Criteria
Inclusion Criteria:

- Age >18 years

- History of type 2 diabetes > 1 month

- Treatment with diet alone, any combination of oral antidiabetic agents, and/or insulin
prior to admission

- Absence of diabetic ketoacidosis

Exclusion Criteria:

- No history of diabetes

- Subjects expected to undergo surgery during the hospitalization course

- Clinically relevant hepatic disease

- Impaired renal function (serum creatinine ≥ 3.0 mg/dL)

- Pregnancy

- Any mental condition rendering the subject unable to give informed consent